# A Study of PALI-2108 in Healthy Volunteers, Patients With Ulcerative Colitis, and Patients With Fibrostenosing Crohn's Disease

> **NCT07428096** · PHASE1 · ACTIVE_NOT_RECRUITING · sponsor: **Palisade Bio** · enrollment: 6 (estimated)

## Conditions studied

- Fibrostenotic Crohn's Disease

## Interventions

- **DRUG:** PALI-2108

## Key facts

- **NCT ID:** NCT07428096
- **Lead sponsor:** Palisade Bio
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** ACTIVE_NOT_RECRUITING
- **Start date:** 2025-10-17
- **Primary completion:** 2026-01-30
- **Final completion:** 2026-03-15
- **Target enrollment:** 6 (ESTIMATED)
- **Last updated:** 2026-02-23

## Collaborators

- Altasciences Company Inc.

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07428096

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07428096, "A Study of PALI-2108 in Healthy Volunteers, Patients With Ulcerative Colitis, and Patients With Fibrostenosing Crohn's Disease". Retrieved via AI Analytics 2026-07-24 from https://api.ai-analytics.org/clinical/NCT07428096. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*